))
Focus on the PARITY Trial, with special guest Michelle Ghert, MD, FRCSC
Manage episode 372330470 series 3411677
Contenuto fornito da Paul Sandford, Mohit Bhandari, and Marc Swiontkowski. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Paul Sandford, Mohit Bhandari, and Marc Swiontkowski o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
In this episode, Marc and Mo are joined by special guest Michelle Ghert, MD, FRCSC (Professor of Surgery at McMaster University and President of the Musculoskeletal Tumor Society) in a discussion of the Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) study that appeared in JAMA as well as the related JBJS supplement focusing on secondary analytic questions.
Links:
- PARITY Supplement in JBJS: https://bit.ly/47fEkqH
- Editorial focusing on PARITY: https://bit.ly/44ExN6Z
- Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) Investigators; Ghert M, Schneider P, Guyatt G, Thabane L, Vélez R, O'Shea T, Randall RL, Turcotte R, Wilson D, Wunder JS, Baptista AM, Cheng EY, Doung YC, Ferguson PC, Giglio V, Hayden J, Heels-Ansdell D, Khan SA, Sampath Kumar V, McKay P, Miller B, van de Sande M, Zumárraga JP, Bhandari M. Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial. JAMA Oncol. 2022 Mar 1;8(3):345-353. doi: 10.1001/jamaoncol.2021.6628. PMID: 34989778; PMCID: PMC8739829. https://bit.ly/3K7MG8S
Subspecialties:
- Infection
- Oncology
- Orthopaedic Essentials
96 episodi
Condividi
